Day: September 25, 2024

VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) — Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQX: NSRPF) is pleased to provide a video update on the Company’s highly prospective Belltopper Gold Project (“Belltopper”), following the Company’s recent announcement titled “Belltopper Mineralisation Modelling Defines Prospectivity” released to the ASX on 25 September 2024 (“Belltopper Announcement”). To view the video update, please follow the link to the Company’s website Novo Resources1.Belltopper is located 120 km northwest of Melbourne and approximately 50 km south of Agnico Eagle’s Fosterville Gold Mine in the Bendigo Zone, an area with historical gold production of more than 60 million ounces. Novo recently completed a six-hole, 2,529 m, diamond drill program in Q2 20242, commensurate with...

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) — Image Protect, Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), Through its subsidiary 2CentTexts.com recently completed a 60-day case study with its major client in the carpet cleaning industry, Steam Pro of Denver CO, proving a 10x ROI (Return on investment), on advertising dollars through the 60 day testing period. This test was successfully administered and managed by 2CentTexts.com and featured text marketing to the Steam Pro database of over 27K customers, featuring discounts and specials for its loyal customers. Steam Pro of Denver Owner Steve Hursh said, “We have never had a stronger return on a marketing spend than with our campaigns with 2CentTexts, and the results are immediate. We will continue to use our 2CentTexts.com service a minimum of...

Company to showcase transformational AirJoule® technology at the Water, Energy, Technology, and Environment Exhibition (WETEX) in Dubai RONAN, Mont., Sept. 25, 2024 (GLOBE NEWSWIRE) — Montana Technologies Corporation (NASDAQ: AIRJ) (“Montana Technologies” or the “Company”), the developer of the transformational AirJoule® technology for atmospheric water generation, today announced that it has established its first international office in the United Arab Emirates (“UAE”) to accelerate the deployment of AirJoule® in the region. “Establishing an office in the UAE will help us to efficiently address the significant demand for AirJoule®’s advanced dehumidification and atmospheric water harvesting capabilities from potential customers in the fast-growing markets of the UAE, the Gulf Cooperation Council countries, and India. Our UAE presence...

Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN FRANCISCO, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, today announced that existing investors have committed a financing of $1.25 million. With these funds the Company plans to work with the U.S. Food and Drug Administration to resolve the remaining IND issue for CER-1236, which is on clinical hold. Vice Chairman Chris Ehrlich will become Chairman and Interim Chief Executive Officer. Brian Atwood has elected to step down as President and CEO to become a consultant to CERo and to Mr....

Partnership Leverages AI Technology from Gold Rock Holdings’ K-Project Division to Enhance Theft Deterrent Solutions and Introduces Safety Data FeaturesZFlo Technologies and LOOT8, Inc. Announce Joint Venture to Revolutionize Package Security, Addressing a $30 Billion Annual ProblemZFlo Technologies (ZFlo) and LOOT8 (loot8.io) a wholly owned subsidiary of Gold Rock Holdings, Inc. (OTC: GRHI) ($GRHI) (“Company”) announce a groundbreaking joint venture aimed at revolutionizing package security and delivery services – https://www.goldrockholdings.com/ https://loot8.io/ & https://www.zflotechnologies.com/VIRGINIA BEACH, Va., Sept. 25, 2024 (GLOBE NEWSWIRE) — ZFlo Technologies (ZFlo) and LOOT8 (loot8.io) a wholly owned subsidiary of Gold Rock Holdings, Inc. (OTC: GRHI) ($GRHI) (“Company”)...

– Patients are preselected for CDKN2A and/or CDKN2B abnormalities – – Safety and efficacy data to be reported at an upcoming oncology medical conference – BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative cancer medicines, today announced that enrollment of 12 patients has been completed as per protocol in Cohort 8 of its Phase 2 stage, proof of concept 065-101 study of fadraciclib (“fadra”), a CDK2/9 inhibitor, in patients with advanced solid tumors and lymphoma. Enrollment of Cohort 5 in patients with T-Cell Lymphoma is continuing. “We are pleased to report that the Cyclacel team has achieved another important milestone by completing...

AI-Powered Commerce Set to Lead Innovation as Industry Booms Market Set for 40-55% Annual Growth, Says Bain Report*NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in AI-driven commerce, today responded to Bain & Company’s forecast of AI’s market explosion, predicting annual growth between 40-55% and a market size approaching $1 trillion by 2027. As AI reshapes industries, Rezolve AI is positioned at the forefront, transforming the commerce landscape through its revolutionary AI-powered solutions. Daniel M. Wagner, CEO of Rezolve iI, remarked, “This report is a testament to AI’s unparalleled potential. Bain’s projections solidify our vision that AI will redefine global commerce, unlocking unprecedented opportunities for businesses to enhance customer engagement and operational...

JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development of orally delivered peptides, and OPKO Health, Inc. (NASDAQ: OPK) (OPKO) announced today topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative research combining a proprietary long-acting oxyntomodulin (OXM) analog developed by OPKO and Entera’s proprietary N-Tab™ technology. The program is focused on developing the first oral dual agonist GLP-1/glucagon peptide as a potential once-daily treatment for patients with obesity, metabolic and fibrotic disorders. OXM is a naturally occurring peptide hormone found in the small intestine that acts to suppress appetite and induce weight loss. Entera and OPKO have completed in vivo proof-of-concept PK/PD studies in rodent and...

HOUSTON, Sept. 25, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in sustainable energy management, today announced that it is on track to successfully complete its initial engagement with the United States Army by Q3 2024. Building on the momentum of this ongoing partnership, the Army will expand its battery contract with the Company to $2.4M. This contract includes the development of additional prototypes and comprehensive environmental qualification testing in accordance with MIL-STD-810E standards. This expanded contract underscores KULR’s commitment to advancing the performance and reliability of silicon anode lithium-ion battery cells under the most demanding conditions. These prototypes will undergo rigorous testing to ensure that...

Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million NEW YORK and TOKYO, Sept. 25, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced its Go IPO client, SBC Medical Group Holdings Inc. (“SBC”), has successfully commenced trading under the symbol “SBC” on the Nasdaq Global Market exchange. HeartCore was initially compensated through an aggregate $900,000 in initial fees and warrants to acquire 2.7% of SBC’s common stock, on a fully diluted basis, which equate to $17 million; in total, HeartCore generated $17.9 million in revenue from the SBC deal, with $17 million to be recognized in Q3 2024. As previously mentioned, of...